2016 annual financial data
Cogent Biosciences, Inc. 2016 Operating margin
Cogent Biosciences, Inc. 2016 operating margin with verified reported values.
Direct answer
Operating margin was -300.08%.
Operating income was -19,070,000 USD and net income was -18,124,000 USD.
Operating cash flow was -18,640,000 USD.
Get free Cogent Biosciences, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,355,000 USD
- Operating income
- -19,070,000 USD
- Net income
- -18,124,000 USD
- Operating cash flow
- -18,640,000 USD